Company intelligence / Profile preview

Moonlight Therapeutics

Marietta, Georgia, United Statesmoonlighttx.com ↗

Ownership: Private
Development stage: Preclinical

Overview

MOON101 successfully desensitized peanut-allergic mice in pre-clinical studies; company has received a multimillion-dollar clinical trial grant to investigate MOON101 in peanut allergic adults and children

Therapeutic areas: Immunology
Modalities: Intradermal immunotherapy
Industry: Biotech

Drug pipeline

1 asset

MOON101

Unknown

Beyond the preview

Go deeper on Moonlight Therapeutics.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Moonlight Therapeutics.

Explore the full profile